Hainan Province Digital Therapeutics Industry Innovation Empowerment Series Events Conclude Successfully, Focusing on Cutting-Edge Application Scenarios
2023Year3Month9Day—10Day, hosted by the Hainan Provincial Health Commission, Organized by VCBeatof“Hainan Province Digital Therapeutics Industry Innovation Empowerment Event——Seminar on Application Scenarios of Digital Therapeutics”Successfully concluded at the Hainan GuesthouseHost。
As an industry conference that has drawn significant attention from digital therapeutics professionals, the two-day event featured a total of over150Guests from various sectors of the industry, including government, hospitals, enterprises, research institutions, and capital markets. Centering on digital therapeutics as the main theme, they focused on key topics such as clinical innovation application scenarios and opportunities, government needs and application scenarios, policy interpretation, government-enterprise and hospital-enterprise collaboration, approval and registration, implementation and development, and product R&D. They engaged in sustained exchanges of ideas and explored new possibilities across nine areas: chronic diseases, oncology, sleep disorders, orthopedics, rehabilitation, mental, behavioral and cognitive disorders, ophthalmology, nutrition, and the Boao Lecheng International Medical Tourism Pilot Zone’s Digital Therapeutics Clinical Research and Translation Base.Presenting an unexpectedly strongInnovationA Feast of Ideas.
In terms of format, this seminar focuses on the practical implementation and application of digital therapeutics products.An Overview of the Policy and Industrial Frontiers in Digital Therapeutics, establishing a tripartite dialogue platform among government agencies, enterprises, and research institutes. The event consisted of four sessions, namely“Seminar on Innovative Application Scenarios for Digital Therapeutics,” “Seminar on Policy Interpretation and Corporate Implementation of Digital Therapeutics,” “Seminar on Hospital-Enterprise Collaboration in Digital Therapeutics (I),” and “Seminar on Hospital-Enterprise Collaboration in Digital Therapeutics (II)” brought together industry professionals through thematic presentations, roundtable discussions, and seminars to assess the development trajectory of digital therapeutics. These initiatives aimed to drive innovative reform and upgrading of the digital therapeutics industry from multiple dimensions and explore new opportunities for industrial growth.
The event brought together distinguished guests from government, industry, academia, research, and healthcare sectors, fostering a vibrant atmosphere for exchange. Government representatives included leaders from the Hainan Provincial Health Commission, Department of Industry and Information Technology, Department of Science and Technology, Healthcare Security Administration, Medical Products Administration, Center for Drug and Medical Device Evaluation and Review, Hainan Banking and Insurance Regulatory Bureau, and Big Data Administration. Also present were heads of various divisions within the Provincial Health Commission—including Personnel, Planning and Information, Finance, System Reform, Industry Development, Disease Control and Prevention, Medical Administration and Hospital Management, Primary Healthcare, Science and Education, Comprehensive Supervision, Elderly Health, and Maternal and Child Health—as well as leaders of health commissions from cities, counties, and autonomous counties across Hainan, and representatives from industrial parks such as the Boao Lecheng International Medical Tourism Pilot Zone, Hainan Eco-Software Park, Haikou High-Tech Industrial Development Zone, and Fuxing City.From the hospital and research sectors, attendees included leaders and department heads from Hainan General Hospital, the First Affiliated Hospital of Hainan Medical University, the Second Affiliated Hospital of Hainan Medical University, Hainan Provincial Second People’s Hospital, Hainan Provincial Anning Hospital, Hainan Provincial Women and Children’s Medical Center, Hainan Eye Hospital, Ruijin Hospital Hainan Branch (Affiliated with Shanghai Jiao Tong University School of Medicine), Sanya Central Hospital, Hainan Provincial Cancer Hospital, Haikou People’s Hospital, Haikou Orthopedics and Diabetes Hospital, and Sanya Women and Children’s Hospital.Representatives from the corporate and investment sectors included leading innovative enterprises such as Viatris, Wuxi Qiyi Medical, Boke Medical, LinkDoc Technology, Shenzhen Beishen Medical, Shenzhen Yuanjian Ruishi, as well as investment institutions long committed to industry development, including Qiming Venture Partners, Pharmaron (CEC PharmaWuXi), Zhilan Health, and Yuanyi Capital.
Zhang Yuhui, a member of the Party Committee and Deputy Director of the Hainan Provincial Health Commission, stated at the conference that only by accelerating practical application can we explore effective pathways for digital therapeutics to drive the transformation and upgrading of the health system. Since last year10Month11Since the official release of the "Several Measures for Accelerating the Development of the Digital Therapeutics Industry in Hainan Province" (hereinafter referred to as the "Several Measures"), it has attracted attention nationwide and even beyond. This is becauseThe First Policy Support Document Covering the Full Lifecycle of Digital Therapeutics Industry Development in China and Globally. Director Yu Hui expressed gratitude to the various departments and bureaus for their strong support of this event, stating that the main objectives of the event are, first, to communicate through discussions to understand the difficulties encountered by all participants in the implementation of policies and to explore solutions, and second, to report on Hainan Province's self-21progress and achievements made since the release of this important document. He stated that Hainan Province has achieved a series of targets set forth in the “Several Measures,” including the selection, review, and final determination of the first batch of20established an experimental center for digital therapeutics, built a public service platform for digital therapeutics, and implemented specialized regional coordination mechanisms and review pathways for digital therapeutics. It was stated that efforts will continue to be made to implement the tasks and measures stipulated in the policy documents, promote the innovative application of digital therapeutics, accelerate the clustered development of digital therapeutics in Hainan, and leverage digital therapeutics as a foundation to drive the digital transformation and upgrading of healthcare in Hainan, enabling it to achieve leapfrog development, so that the public can enjoy comprehensive, full-cycle health services.
(Deputy Director Zhang Yuhui delivered remarks at the event)
Wu Minsheng, Director of the Department of Elderly Health at the Hainan Provincial Health Commission, stated that Hainan will launch a pilot program for digital therapeutics in cognitive rehabilitation for the elderly this year. The implementation plan for the pilot has already been formulated and issued.3This month will launch promotional campaigns for brain health awareness and pilot initiatives, and issue a notice to the industry regarding the call for proposals and selection of solutions for pilot application scenarios of digital therapeutics for cognitive rehabilitation. It is expected that4Monthly deployment of the cognitive impairment screening information system for the elderly, with a dedicated user-side screening interface provided.APPor via mini-programs. Looking ahead, China’s 14th Five-Year Plan Outline has designated brain science and brain-inspired research as key priority areas for tackling cutting-edge scientific and technological challenges. Multidisciplinary collaborative efforts will be organized to achieve significant progress in the research and development of diagnostic and therapeutic technologies for elderly brain health.
(Shared by Wu Minsheng, Director of the Department of Elderly Health, Hainan Provincial Health Commission)
HainanWang Yanfang, Director of the Health Industry and International Cooperation Bureau, Provincial Health CommissionThis article provides a comprehensive overview of the development of the digital therapeutics industry in Hainan, covering strategic considerations, operational approaches, progress made, objectives, and future prospects. She noted that advances in human medicine have led to an increase in average life expectancy, while the application of digital technologies has brought about fundamental changes in medical development. Digital therapeutics can directly intervene in disease management and represent a key direction for the future of medicine, signaling that the application of digital technologies in the healthcare sector has entered4.0era. Digital therapeutics represent the convergence of the dual helix development trends in medical technology advancement and digitalization. Subsequently, Director Wang Yanfang proceeded fromDigital Therapeutics: Clinical Research Demonstration Base Development, Product Registration and Approval, Product Promotion and Application, Exploration of Reimbursement Models, Publicity and Industry Cluster Building, Standardized Development and SafeguardsInterpretation and Sharing of Hainan Province21policies and their implementation, and stated that it will promote the development of Hainan into a global innovation hub for digital therapeutics, establishing itself as a world-renowned center of excellence in the digital therapeutics industry.
(HainanWang Yanfang, Director of the Health Industry and External Cooperation Bureau of the Provincial Health Commission, Shares Hainan’s Policies)
At the Seminar on Hospital-Enterprise Collaboration in Digital Therapeutics, participants discussed the development progress, key innovations, and challenges of digital therapeutics clinical trial centers across five domains: chronic diseases, oncology, sleep disorders, orthopedics, and the Clinical Research and Translation Base for Digital Therapeutics in the Boao Lecheng International Medical Tourism Pilot Zone. They engaged in in-depth discussions on focal topics including opportunities, models, and processes for hospital-enterprise collaboration.
Haikou Orthopedics and Diabetes Hospital, Orthopedic Digital Therapeutics Clinical Trial Center,Haikou Orthopedics and Diabetes Hospital、Chronic Disease Digital Therapeutics Clinical Trial Center，Hainan Provincial People's Hospital、Oncology Digital Therapeutics Clinical Trial Center，The First Affiliated Hospital of Hainan Medical University、Clinical Trial Center for Orthopedic Digital Therapeutics, Sanya Central Hospital, Clinical Trial Center for Digital Sleep Therapy,Ruijin Hospital, Shanghai Jiao Tong University School of Medicine、Boao Lecheng Pilot Zone Clinical Research and Translation Base for Digital Therapeutics, Hainan Provincial Women and Children's Hospital, Clinical Trial Center for Nutritional Digital Therapeutics,The First Affiliated Hospital of Hainan Medical University、Clinical Trial Center for Rehabilitation Digital Therapeutics，Haikou People's Hospital、Rehabilitation Digital Therapeutics Clinical Trial CenterRepresentatives from the Hainan Provincial Eye Hospital and its Clinical Trial Center for Digital Therapeutics in Ophthalmology, the Hainan Provincial Women and Children’s Hospital and its Clinical Trial Center for Digital Therapeutics in Mental, Behavioral, and Cognitive Disorders, and the Hainan Provincial Anning Hospital and its Clinical Trial Center for Digital Therapeutics in Mental, Behavioral, and Cognitive Disorders successively introduced their respective institutions’ innovative explorations.
Following two days of insights sharing and interactive exchanges, digital therapeutics professionals in attendance expressed greater confidence and hope for the future of the industry, committing to jointly support and drive its robust growth.